cladribine has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavez, JC; Juárez Salcedo, LM; Klippenstein, D; Sandoval-Sus, J; Zhang, L | 1 |
| Liang, NC; Liu, XG; Zhu, F | 1 |
| Hakimian, D; Pandolfino, J; Rademaker, AW; Tallman, MS | 1 |
3 other study(ies) available for cladribine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Excellent outcome of hairy cell leukaemia with extensive mesenteric infiltration following cladribine therapy.
Topics: Antineoplastic Agents; Cladribine; Humans; Leukemia, Hairy Cell; Lymphadenopathy; Male; Mesentery; Middle Aged; Neoplasm Invasiveness; Splenomegaly; Treatment Outcome | 2016 |
[nhibitory effect of adenosine analogues on invasion of human ovarian cancer cell line HO-8910PM].
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cladribine; Deoxyadenosines; Female; Histone Deacetylases; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Ovarian Neoplasms; Repressor Proteins; RNA, Messenger; Trans-Activators | 2004 |
Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activity.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Cell Division; Cholesterol; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neoplasm Invasiveness; Splenomegaly | 1997 |